Summer 2025 Internship Program

SUMMER 2025 INTERNSHIP PROGRAM

At Pierre Fabre Pharmaceuticals Inc. our mission is to deliver breakthrough therapies in oncology and rare diseases to patient populations with high unmet needs and limited treatment options. Our belief is that every time we care for a single person, we make the whole world better.  We are the US pharmaceutical subsidiary of Pierre Fabre Laboratories Worldwide, a foundation-owned company with 7 decades of impact. Pierre Fabre Laboratories is a truly global healthcare company, established in 43 countries, with products distributed in 119 territories across the globe. Pierre Fabre's foundation ownership enhances our ability to focus on creating long-term value for patients.   

Building on the legacy of Pierre Fabre Laboratories, innovation is our life blood and patient experience drives everything we do. We aspire to design and develop therapeutic solutions inspired by patients and healthcare professionals; draw on science and nature as perpetual sources of inspiration; develop long-term partnerships with researchers and innovators worldwide; and place pharmaceutical ethics and climate transition at the heart of our action.  

Pierre Fabre Pharmaceuticals is headquartered in Parsippany, NJ alongside Pierre Fabre USA Inc., a Pierre Fabre Laboratories subsidiary focused on dermatology and cosmetics.  

SUMMARY: 

The intern will have the opportunity to gain an understanding of the specific Cell & Gene Therapy (C>) space within the US pharmaceutical industry by immersing in the operations of Pierre Fabre Pharmaceuticals, Inc. (PFP), Pierre Fabre’s Group US Medical affiliate. 

Over the course of the program, the intern will be responsible for 2 projects: (i) Cell & Gene Therapy competitive intelligence and (ii) Legal & Compliance support to General Counsel. 

ESSENTIAL FUNCTIONS:

Cell & Gene Therapy competitive intelligence

Using publicly available information (open-source data, investor relations filings and presentations, market research reports) and leveraging the PFP internal stakeholders:

Industry landscape analysis: Create a list of companies with approved Cell & Gene Therapy products in the US or currently in late-stage development (Phase III) with key characteristics: name of treatment, indication, therapeutic area, year of launch, expected patient potential, sales, etc.). As a base list, the intern can research the following treatments:

Kymriah (Tisagenlecleucel) – Novartis

Yescarta (Axicabtagene Ciloleucel) – Gilead (Kite Pharma)

Breyanzi ((Lisocabtagene Maraleucel) – Bristol Myers Squibb

Tecentriq (Atezolizumab) – Roche (Genentech)

Carvykti (Ciltacabtagene autoleucel) – Janssen Biotech

Casgevy (Exagamglogene Autotemcel) – Vertex Pharmaceuticals

Omisirge (Omidubicel-onlv) – Gamida Cell

Ryoncil (Remestemcel-L-rknd) – Mesoblast

Tecelra (afamitresgene autoleucel) – Adaptimmune

Cema-Cel (Cemacabtagene Ansegedleucel) – Allogene Therapeutics

Competitor profiling: Based on the compiled industry landscape list, choose the 2-3 most comparable companies and create competitor profile 1-pagers highlighting product offering, market positioning, SWOT analysis and financial performance

Commercial activation drivers: For a selection of cell & gene therapies recently launched (2023 through 2025) in the US, analyze the metrics used to monitor commercial readiness and site activation progress. Those metrics will then be compared with PFP’s own site activation KPIs for benchmarking.

Presentation and reporting: At the end of the project, present to the PFP Leadership Team a summary of observations and potential actionable insights on the US Cell & Gene Therapy market and recent launches analogs (Powerpoint presentation leveraging PFP slide template)

Legal & Compliance support to General Counsel

Comparative analysis of contract and commercial laws across the US and nuances in contract law implementation

Training slides on Legal Privilege and impact on Discovery Proceedings

Research on recent enforcement decision within the pharmaceutical sector – Key issues being targeted by federal and state law enforcement bodies 

Training platform with alerts from public sources for legal department to leverage for latest updates in pharma enforcement.  

Other activities

The list and scope of assigned projects can be amended during the duration of the program, in which case the assignment description will be discussed and agreed upon between the intern and its supervisor.

In addition to assigned projects, the intern will be invited to participate in operational meetings and get introduced to key internal stakeholders (PFP Leadership Team). This will enable the intern to develop a better understanding of the dynamics and challenges of a growing company looking to launch a commercial cell therapy on the US market. 

PRACTICAL EXPERIENCE

• Summer 2025 internship program will begin the week of May 26th, 2025, and end June 20th, 2025 (4 weeks). It can be renewed monthly in case of mutual agreement of Pierre Fabre Pharmaceuticals and intern. 
• The internship is a part-time role of 3 days per week (24 hours), including Tuesdays, Thursdays and a floating day. 
• Tuesdays and Thursdays will be worked from PFP’s office in Secaucus, NJ. Floating day can be worked remotely. 
• Intern will be supervised by Arthur Ginies, Business Operations Lead. His HR manager will be George Sciacca. 
• Intern will be provided with a Pierre Fabre laptop and email address for the duration of the program. The laptop must be returned to Pierre Fabre’s IT Team on the last day of the assignment. 
• During the full duration of the program, intern must comply with Pierre Fabre’s Codes of Conduct and Ethics. All information gathered the assignment or provided to intern is confidential and proprietary to Pierre Fabre. 

WORK ENVIRONMENT:

Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions. 

LOCATION:

• Hybrid-Secaucus, NJ.

FOR MASSACHUSETTS CANDIDATES ONLY: Pierre Fabre Pharmaceuticals does not require or administer a lie detector test as a condition of employment or continued employment. An employer who violates the law shall be subject to criminal penalties and civil liability. 

Pierre Fabre

Pierre Fabre has been recognized by Forbes as one of the "World's Best Employers" for the 3rd year running. 

https://www.pierre-fabre.com/en-us 

True to My Nature 

Pierre Fabre is an equal employment opportunity employer and does not discriminate against any applicant because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, gender expression and identity, disability, genetic information, veteran status, military status, application for military service or any other class protected by state or federal law.